{"id":"W2996433778","doi":"10.1016/j.ejca.2019.11.006","title":"Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Osimertinib; Gefitinib; Medicine; Erlotinib; Lung cancer; Internal medicine; Erlotinib Hydrochloride; Post-hoc analysis; Oncology; Discontinuation; Clinical endpoint; Performance status; Clinical trial; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001481126,0.0003507173,0.000693494,0.0002067179,0.00005941653,0.000036173,0.0001588785,0.00004255464,0.001381689],"category_scores_gemma":[0.00005768518,0.0002202625,0.0001563744,0.0003560277,0.00003928262,0.0002572501,0.0000415237,0.0004000336,0.00002948253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005033337,"about_ca_system_score_gemma":0.0007340283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002853855,"about_ca_topic_score_gemma":0.0001939224,"domain_scores_codex":[0.9975134,0.0001245478,0.00100105,0.0003617489,0.0005957892,0.0004034652],"domain_scores_gemma":[0.9975275,0.0001194973,0.00110722,0.0003308664,0.0006438527,0.0002710937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01172416,0.0005248149,0.9504127,0.0000602409,0.001474835,0.0005630903,0.00200261,0.001317651,0.000477414,4.557417e-7,0.000755529,0.03068651],"study_design_scores_gemma":[0.05823769,0.002351116,0.9314697,0.001113493,0.001225698,0.000005614242,0.0005191807,0.00005691776,0.000900285,5.371486e-7,0.003811862,0.0003078753],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991101,0.001430383,0.00002063723,0.0004352545,0.001632533,0.001021266,0.00009309446,0.000026894,0.004238995],"genre_scores_gemma":[0.9967675,0.0001985489,0.0008403907,0.0005325807,0.0001546957,0.00002775294,0.00005444394,0.0001092161,0.001314835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04651354,"threshold_uncertainty_score":0.9995312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01277167070734162,"score_gpt":0.2964873808127632,"score_spread":0.2837157101054215,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}